Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun;16(3):260-266.
doi: 10.1007/s12519-020-00368-y. Epub 2020 Jun 5.

SARS-CoV-2 infection in infants under 1 year of age in Wuhan City, China

Affiliations

SARS-CoV-2 infection in infants under 1 year of age in Wuhan City, China

Dan Sun et al. World J Pediatr. 2020 Jun.

Abstract

Background: The clinical characteristics and outcome of COVID-19 in children are different from those in adults. We aimed to describe the characteristics of infants under 1 year of age (excluding newborns) with COVID-19.

Methods: We retrospectively retrieved data of 36 infants with SARS-CoV-2 infection in Wuhan Children's Hospital from January 26 to March 22, 2020. Clinical features, chest imaging findings, laboratory tests results, treatments and clinical outcomes were analyzed.

Results: The mean age of the infected infants was 6.43 months, with a range of 2-12 months. 61.11% of the patients were males and 38.89% females. 86.11% of the infants were infected due to family clustering. Cough (77.78%) and fever (47.22%) were the most common clinical manifestations. Chest CT scan revealed 61.11% bilateral pneumonia and 36.11% unilateral pneumonia. 47.22% of the infants developed complications. Increased leucocytes, neutrophils, lymphocytes, and thrombocytes were observed in 11.11, 8.33, 36.11 and 44.44% of infants, respectively. Decreased leucocytes, neutrophils, thrombocyte and hemoglobin were observed in 8.33, 19.44, 2.78 and 36.11% of infants, respectively. Increased C-reactive protein, procalcitonin, lactate dehydrogenase, alanine aminotransferase, creatine kinase and D-dimer were observed in 19.44, 67.74, 47.22, 19.44, 22.22 and 20.69% of infants, respectively. Only one infant had a high level of creatinine. Co-infections with other respiratory pathogens were observed in 62.86% of infants. CD3 (20.69%), CD4 (68.97%), CD19 (31.03%) and Th/Ts (44.83%) were elevated; CD8 (6.9%) and CD16+CD56 (48.28%) was reduced. IL-4 (7.69%), IL-6 (19.23%), IL-10 (50%), TNF-α (11.54%) and IFN-γ (19.23%) were elevated. Up to March 22, 97.22% of infants recovered, while a critical ill infant died. When the infant's condition deteriorates rapidly, lymphocytopenia was discovered. Meanwhile, C-reactive protein, D-dimer, alanine aminotransferase, creatine kinase, creatinine, IL-6 and IL-10 increased significantly.

Conclusions: In the cohort, we discovered that lymphocytosis, elevated CD4 and IL-10, and co-infections were common in infants with COVID-19, which were different from adults with COVID-19. Most infants with COVID-19 have mild clinical symptoms and good prognosis.

Keywords: COVID-19; Coronavirus infant infection; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

All the authors declared no conflicts of interest.

Figures

Fig. 1
Fig. 1
Chest CT images of eight infants with COVID-19. Bilateral pneumonia (ad): a blurred shadow of the left and right inferior lungs; b the brightness of bilateral lungs is uneven, with thin scattered patches; c multiple patchy ground glass opacity can be seen in bilateral lungs; d scattered ground glass opacity of both lungs. Unilateral pneumonia (eh): e patchy blurry shadows and cord-like dense shadows of the upper and lower lobe of right lung; f patchy ground glass opacity in the posterior segment of the right upper lobe and the posterior base of the lower lobe, local cord-like dense shadows, thickening of the right interlobular fissure; g patchy ground glass opacity and increased short strip density of the left lower lung; h increased patchy density of the left lung

Comment in

References

    1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5. - DOI - PMC - PubMed
    1. Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020;368:m606. doi: 10.1136/bmj.m606. - DOI - PMC - PubMed
    1. WHO. Coronavirus disease (COVID-2019) situation reports. April 15, 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/2.... Accessed 10 Apr 2020.
    1. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020 doi: 10.1056/NEJMoa2002032. - DOI - PMC - PubMed
    1. Jiang F, Deng L, Zhang L, Cai Y, Cheung CW, Xia Z. Review of the clinical characteristics of coronavirus disease 2019 (COVID-19) J Gen Intern Med. 2020 doi: 10.1007/s11606-020-05762-w. - DOI - PMC - PubMed